Dr. Alexander Bondoc · Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis
Follow
Article1 min read·Published Jan 2023Older

Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2023 · 1 min read

In brief

In brief

This review examines how posttranslational modifications of glypican-3 (GPC3), including cleavage and glycosylation, influence its oncogenic role in hepatocellular carcinoma. The authors propose that dysregulated PTM of GPC3 drives liver carcinogenesis and epithelial-mesenchymal transition, offering insights for targeted drug development.

Written by the GCMD Library team from the article.

Alexander Bondoc

Glypican-3 (GPC3) is a cell-surface glycoprotein that is frequently overexpressed in hepatocellular carcinoma (HCC). GPC3 undergoes extensive posttranslational modification (PTM) including cleavage and glycosylation. This review focuses on the structure and function of GPC3 in liver cancer, highlighting the PTM of the tertiary and quaternary structures of GPC3 as a potential oncogenic regulatory mechanism. We propose that the function of GPC3 in normal development can vary with extensive PTM and that dysregulation of these processes leads to disease. Defining the regulatory impact of these modifications can provide a deeper understanding of the role of GPC3 in oncogenesis, epithelial-mesenchymal transition, and drug development. Through review of current literature, this article provides a unique perspective on the role of GPC3 in liver cancer, focusing on potential regulatory mechanisms of PTM on GPC3 function at the molecular, cellular, and disease level.

Statements in this article

  1. Glypican-3 is a cell-surface glycoprotein that is frequently overexpressed in hepatocellular carcinoma.

    Established
  2. Glypican-3 undergoes extensive posttranslational modification including cleavage and glycosylation.

    Established
  3. The function of Glypican-3 in normal development can vary with extensive posttranslational modification.

    Research
  4. Dysregulation of posttranslational modification processes of Glypican-3 leads to disease.

    Research
  5. Defining the regulatory impact of posttranslational modifications can provide a deeper understanding of the role of Glypican-3 in oncogenesis, epithelial-mesenchymal transition, and drug development.

    Research

Read it at the source ↗

Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.